{
    "nct_id": "NCT04803305",
    "official_title": "A 6-WEEK, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN STUDY TO ASSESS THE EFFECT OF REPEATED SUBCUTANEOUS ADMINISTRATION OF PF-06946860 ON APPETITE IN PARTICIPANTS WITH ADVANCED CANCER AND ANOREXIA, FOLLOWED BY AN 18-WEEK OPEN-LABEL TREATMENT PERIOD",
    "inclusion_criteria": "* Documented diagnosis of non-small cell lung, pancreatic, colorectal, prostate, breast or ovarian cancer which, in the treating oncologist's assessment, is considered advanced.\n* Anorexia as defined by a score of â‰¤5 in the Cancer-Related Cachexia Symptom Assessment Appetite 7-day recall scale\n* Meets any of the following criteria at Randomization:\n\n  * Not currently receiving antineoplastic therapy\n  * On standard of care systemic antineoplastic therapy or treatment without curative intent\n* Signed informed consent.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Receiving tube feedings or parenteral nutrition at the time of Screening or Randomization.\n* Current active reversible causes of decreased food intake.\n* Current, severe gastrointestinal disease\n* Participants with known symptomatic brain metastases requiring steroids.\n* Active uncontrolled bacterial, fungal, or viral infection, including HBV, HCV, HIV or participants with known AIDS-related illness\n* inadequate renal or liver function.\n* Women who are pregnant or breast-feeding",
    "miscellaneous_criteria": "Key"
}